Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Z5CX
|
||||
| Former ID |
DNC009565
|
||||
| Drug Name |
N-(3,3-Diphenyl)propyl-2,2-diphenylacetamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529563] | ||
| Formula |
C29H27NO
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)C(CCNC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=<br />CC=C4
|
||||
| InChI |
1S/C29H27NO/c31-29(28(25-17-9-3-10-18-25)26-19-11-4-12-20-26)30-22-21-27(23-13-5-1-6-14-23)24-15-7-2-8-16-24/h1-20,27-28H,21-22H2,(H,30,31)
|
||||
| InChIKey |
LMRDWMVRJNJYIQ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cannabinoid receptor 2 | Target Info | Inhibitor | [529563] | |
| Cannabinoid receptor 1 | Target Info | Inhibitor | [529563] | ||
| PANTHER Pathway | Endogenous cannabinoid signaling | ||||
| Pathway Interaction Database | N-cadherin signaling events | ||||
| References | |||||